PPP2R2A and prostate adenocarcinoma: Importantly, hemizygous loss of PPP2R2A expression correlated with poorer prognosis, based on Kaplan-Meier estimates of disease-free survival (DFS) using TCGA data from patients with prostate adenocarcinoma (Fig. 1d, p-value 0.0466).